Sciam - cover

From the March 2009 Scientific American Magazine | 5 comments

New Tactics in the Fight against Tuberculosis ( Preview )

The pandemic is growing in many places, and strains resistant to all existing drugs are emerging. To fight back, biologists are applying a host of cutting-edge drug development strategies

By Clifton E. Barry III and Maija S. Cheung   

 

Modern Plague:
Every year tuberculosis kills nearly two million people and infects some eight million more. Here a patient in Mumbai, India, is treated for a highly drug-resistant form of the disease.
James Nachtwey VII

e-mail print comment

Key Concepts

  • Tuberculosis is second only to HIV as the worldwide cause of death from infection, and the pandemic is growing in many places.
  • TB is caused by a bacterium. Most cases are treatable, but strains resistant to first- and second-line drugs are on the rise.
  • Conventional approaches to developing new antibiotics and vaccines against the disease have mostly failed.
  • New tools are enabling scientists to study the TB-causing bacterium in greater detail, offering unprecedented insight into the interactions between pathogen and host. The results are exposing promising new targets for drug therapy

Bubonic plague, smallpox, polio, HIV—the timeline of history is punctuated with diseases that have shaped the social atmospheres of the eras, defined the scope of science and medicine, and stolen many great minds before their time. But there is one disease that seems to have stalked humanity far longer than any other: tuberculosis. Fossil evidence indicates that TB has haunted humans for more than half a million years. No one is exempt. It affects rich and poor, young and old, risk takers and the abstinent. Simply by coughing, spitting or even talking, an infected individual can spread the bacterium that causes the disease.

Today TB ranks second only to HIV among infectious killers worldwide, claiming nearly two million lives annually, even though existing drugs can actually cure most cases of the disease. The problem is that many people lack access to the medicines, and those who can obtain the drugs often fail to complete the lengthy treatment regimen.

Graphic - Get the Rest of the Article
Graphic - Subscribe     Graphic - Buy this Issue
Already a Digital subscriber? Sign-in Now
If your institution has site license access, enter here.

Read Comments (5) | Post a comment


Share
Propeller    Digg!  Reddit delicious  Fark 
Slashdot    RT @sciam New Tactics in the Fight against TuberculosisTwitter Review it on NewsTrust 
sharebar end

You Might Also Like


Discuss This Article


Click here to submit your comment.

VIEW:

2,573 characters remaining
 
  Email me when someone responds to this discussion.
 

risk free issuefree gift

Sciam - cover Email:
Name:
Address:
Address 2:
City:
State:  
spacer



World Changing Ideas



Editor's Pick


Newsletter

Health & Medicine Newsletter

Get weekly coverage delivered to your inbox


 Podcasts

  • 60-Second Science     RSS  · iTunes Botoxed Face Impairs Bad Feelings
    click to enable

    Download

  • 60-Second Science     RSS  · iTunes Distracted Customers' Wait Times Fly
    click to enable

    Download





ADVERTISEMENT
 
 


Also on Scientific American


© 2010 Scientific American, a division of Nature America, Inc. All Rights Reserved.
ADVERTISEMENT